Moore Kuehn Encourages BLU, STSA, RXDX, STSA, and CHRA Investors to Contact Law Firm

NEW YORK, April 21, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.  Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.

Moore Kuehn is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: 

• BELLUS Health Inc. (NASDAQ: BLU)

BELLUS Health has agreed to merge with GSK Plc. Under the proposed transaction, BELLUS Health shareholders will receive $14.75 in cash per share.

• Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA)

Satsuma Pharmaceuticals has agreed to merge with Shin Nippon Biomedical Laboratories. Under the proposed transaction, Satsuma Pharmaceuticals shareholders will receive $0.91 in cash per share.

• Prometheus Biosciences, Inc. (NASDAQ: RXDX)

Prometheus Biosciences has agreed to merge with Merck & Co.  Under the proposed transaction, Prometheus Biosciences shareholders will receive $200.00 in cash per share.

• Charah Solutions, Inc. (OTC: CHRA)

Charah Solutions has agreed to merge with SER Capital Partners. Under the proposed transaction, Charah Solutions shareholders will receive $6.00 in cash per share.

Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq. by email at [email protected].  The consultation and case are free with no obligation to you.  Moore Kuehn pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

Moore Kuehn is a 5-star Google client-rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims.  For additional information about Moore Kuehn, please visit http://www.moorekuehn.com/practice/new-york-securities-litigation/.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8^th Floor
New York, New York 10005
[email protected]
(212) 709-8245

SOURCE Moore Kuehn, PLLC

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED